array:19 [
  "pii" => "X0211699500025400"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:77"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1417
    "formatos" => array:3 [
      "EPUB" => 160
      "HTML" => 1014
      "PDF" => 243
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025396"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:78-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1594
      "formatos" => array:3 [
        "EPUB" => 155
        "HTML" => 1115
        "PDF" => 324
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Polimorfismo genético del sistema renina-angiotensina en pacientes con poliquistosis renal: implicaciones patogénicas y terapéuticas"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "78"
          "paginaFinal" => "79"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "P. ARANDA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "P. ARANDA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025396?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025396/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025419"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:76"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1444
      "formatos" => array:3 [
        "EPUB" => 154
        "HTML" => 1019
        "PDF" => 271
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "76"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "T. B. DRÜEKE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "T. B. DRÜEKE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025419?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025419/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "The effects of anemia on cardiovascular status"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "77"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "R. N. FOLEY"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "R. N. FOLEY"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 The effects of anemia on cardiovascular status R. N. Foley Left ventricular enlargement is a powerful predictor of cardiac failure and death in endstage renal disease. Regression improves prognosis. We have previously shown, in a long-term prospective cohort of dialysis patients, that sustained anemia is associated with cardiac overload, cardiac enlargement, cardiac failure and death. Recent observational work confirms that this process usually starts early in chronic renal failure, and consistently implicates declining hemoglobin and rising blood pressure levels as being etiological. We recently reported findings on a group of dialysis patients with 4 consecutive annual echocardiograms, following inception of dialysis therapy. Progressive left ventricular dilatation was seen, mostly, but not exclusively, in the first year. Anaemia was clearly associated with this process, mostly in the first year of dialysis therapy: the cardiac enlargement seen after I year was independent of standard risk factors, including haemoglobin levels. These data suggest that earlier treatment of anemia may achieve more than later treatment. Recent randomised trial activity, including ours, intervened relatively late in the anaemia-cardiomyopathy-cardiac failure-death continuum. The United States Normal Hematocrit Trial showed that a policy of later intervention with a normal hematocrit failed to prolong life and led to increased hemodialysis access loss, in patients with symptomatic ischaemic heart disease or cardiac failure. The Canadian Normalization of Hemoglobin Trial, which targeted hemodialysis patients without symptoms of cardiac disease, showed that higher targets failed to regress established left ventricular hypertrophy and dilatation. The higher target hemoglobin level, however, prevented the development of LV dilatation, and was associated with clear quality of life benefits, at no cost in terms of access loss and cardiovascular events. Thus, best evidence suggests that early intervention to avoid low hemoglobin levels improves cardiac outcomes in chronic renal failure patients. Several ongoing trials will soon confirm the benefits and risk of such an approach. 77 "
    "pdfFichero" => "P7-E170-S140-A1914.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025400/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025400/v0_201502091333/en/P7-E170-S140-A1914.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025400?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

The effects of anemia on cardiovascular status
R. N. FOLEY
Leído
3743
Veces
se ha leído el artículo
1466
Total PDF
2277
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699500025400"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:77"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1417
    "formatos" => array:3 [
      "EPUB" => 160
      "HTML" => 1014
      "PDF" => 243
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025396"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:78-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1594
      "formatos" => array:3 [
        "EPUB" => 155
        "HTML" => 1115
        "PDF" => 324
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Polimorfismo genético del sistema renina-angiotensina en pacientes con poliquistosis renal: implicaciones patogénicas y terapéuticas"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "78"
          "paginaFinal" => "79"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "P. ARANDA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "P. ARANDA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025396?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025396/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025419"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:76"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1444
      "formatos" => array:3 [
        "EPUB" => 154
        "HTML" => 1019
        "PDF" => 271
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«HIPERTENSIÓN Y ENFERMEDAD CARDIOVASCULAR EN PACIENTES CON INSUFICIENCIA RENAL CRÓNICA» Effects of hyperparathyroidism in the pathogenesis of hypertension, left ventricular hypertrophy and cardiovascular disease in CRF patients"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "76"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "T. B. DRÜEKE"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "T. B. DRÜEKE"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025419?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025419/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "The effects of anemia on cardiovascular status"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "77"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "R. N. FOLEY"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "R. N. FOLEY"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 The effects of anemia on cardiovascular status R. N. Foley Left ventricular enlargement is a powerful predictor of cardiac failure and death in endstage renal disease. Regression improves prognosis. We have previously shown, in a long-term prospective cohort of dialysis patients, that sustained anemia is associated with cardiac overload, cardiac enlargement, cardiac failure and death. Recent observational work confirms that this process usually starts early in chronic renal failure, and consistently implicates declining hemoglobin and rising blood pressure levels as being etiological. We recently reported findings on a group of dialysis patients with 4 consecutive annual echocardiograms, following inception of dialysis therapy. Progressive left ventricular dilatation was seen, mostly, but not exclusively, in the first year. Anaemia was clearly associated with this process, mostly in the first year of dialysis therapy: the cardiac enlargement seen after I year was independent of standard risk factors, including haemoglobin levels. These data suggest that earlier treatment of anemia may achieve more than later treatment. Recent randomised trial activity, including ours, intervened relatively late in the anaemia-cardiomyopathy-cardiac failure-death continuum. The United States Normal Hematocrit Trial showed that a policy of later intervention with a normal hematocrit failed to prolong life and led to increased hemodialysis access loss, in patients with symptomatic ischaemic heart disease or cardiac failure. The Canadian Normalization of Hemoglobin Trial, which targeted hemodialysis patients without symptoms of cardiac disease, showed that higher targets failed to regress established left ventricular hypertrophy and dilatation. The higher target hemoglobin level, however, prevented the development of LV dilatation, and was associated with clear quality of life benefits, at no cost in terms of access loss and cardiovascular events. Thus, best evidence suggests that early intervention to avoid low hemoglobin levels improves cardiac outcomes in chronic renal failure patients. Several ongoing trials will soon confirm the benefits and risk of such an approach. 77 "
    "pdfFichero" => "P7-E170-S140-A1914.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025400/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025400/v0_201502091333/en/P7-E170-S140-A1914.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025400?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 7 8 15
2024 Octubre 33 36 69
2024 Septiembre 26 21 47
2024 Agosto 47 57 104
2024 Julio 36 31 67
2024 Junio 41 23 64
2024 Mayo 53 28 81
2024 Abril 34 13 47
2024 Marzo 33 26 59
2024 Febrero 29 36 65
2024 Enero 23 12 35
2023 Diciembre 24 20 44
2023 Noviembre 25 24 49
2023 Octubre 27 29 56
2023 Septiembre 43 23 66
2023 Agosto 23 19 42
2023 Julio 17 20 37
2023 Junio 42 23 65
2023 Mayo 24 31 55
2023 Abril 17 15 32
2023 Marzo 15 15 30
2023 Febrero 18 17 35
2023 Enero 14 22 36
2022 Diciembre 28 25 53
2022 Noviembre 23 23 46
2022 Octubre 29 35 64
2022 Septiembre 26 20 46
2022 Agosto 23 39 62
2022 Julio 23 37 60
2022 Junio 17 27 44
2022 Mayo 21 21 42
2022 Abril 31 35 66
2022 Marzo 19 30 49
2022 Febrero 34 30 64
2022 Enero 21 22 43
2021 Diciembre 15 37 52
2021 Noviembre 21 29 50
2021 Octubre 23 43 66
2021 Septiembre 14 25 39
2021 Agosto 22 21 43
2021 Julio 12 23 35
2021 Junio 12 12 24
2021 Mayo 17 25 42
2021 Abril 16 22 38
2021 Marzo 19 12 31
2021 Febrero 21 8 29
2021 Enero 5 6 11
2020 Diciembre 9 9 18
2020 Noviembre 10 4 14
2020 Octubre 8 5 13
2020 Septiembre 4 4 8
2020 Agosto 17 6 23
2020 Julio 12 5 17
2020 Junio 11 5 16
2020 Mayo 10 7 17
2020 Abril 19 10 29
2020 Marzo 10 6 16
2020 Febrero 19 8 27
2020 Enero 24 14 38
2019 Diciembre 9 14 23
2019 Noviembre 5 3 8
2019 Octubre 9 2 11
2019 Septiembre 8 10 18
2019 Agosto 4 10 14
2019 Julio 8 8 16
2019 Junio 7 3 10
2019 Mayo 7 6 13
2019 Abril 43 22 65
2019 Marzo 10 6 16
2019 Febrero 9 15 24
2019 Enero 11 4 15
2018 Diciembre 15 15 30
2018 Noviembre 18 5 23
2018 Octubre 28 10 38
2018 Septiembre 19 5 24
2018 Agosto 18 4 22
2018 Julio 13 5 18
2018 Junio 14 8 22
2018 Mayo 11 5 16
2018 Abril 12 5 17
2018 Marzo 16 5 21
2018 Febrero 14 4 18
2018 Enero 9 3 12
2017 Diciembre 10 3 13
2017 Noviembre 13 5 18
2017 Octubre 11 2 13
2017 Septiembre 7 3 10
2017 Agosto 18 8 26
2017 Julio 6 5 11
2017 Junio 12 3 15
2017 Mayo 4 1 5
2017 Abril 9 1 10
2017 Marzo 6 6 12
2017 Febrero 8 1 9
2017 Enero 2 0 2
2016 Diciembre 10 4 14
2016 Noviembre 9 3 12
2016 Octubre 28 2 30
2016 Septiembre 36 1 37
2016 Agosto 51 2 53
2016 Julio 77 0 77
2016 Junio 64 0 64
2016 Mayo 52 0 52
2016 Abril 14 0 14
2016 Marzo 22 0 22
2016 Febrero 14 0 14
2016 Enero 17 0 17
2015 Diciembre 35 0 35
2015 Noviembre 24 0 24
2015 Octubre 26 0 26
2015 Septiembre 29 0 29
2015 Agosto 11 0 11
2015 Julio 17 0 17
2015 Junio 8 0 8
2015 Mayo 14 0 14
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?